International multicenter examination of MOG antibody assays
Top Cited Papers
Open Access
- 1 March 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
Objective To compare the reproducibility of 11 antibody assays for immunoglobulin (Ig) G and IgM myelin oligodendrocyte glycoprotein antibodies (MOG-IgG and MOG-IgM) from 5 international centers. Methods The following samples were analyzed: MOG-IgG clearly positive sera (n = 39), MOG-IgG low positive sera (n = 39), borderline negative sera (n = 13), clearly negative sera (n = 40), and healthy blood donors (n = 30). As technical controls, 18 replicates (9 MOG-IgG positive and 9 negative) were included. All samples and controls were recoded, aliquoted, and distributed to the 5 testing centers, which performed the following antibody assays: 5 live and 1 fixed immunofluorescence cell-based assays (CBA-IF, 5 MOG-IgG, and 1 MOG-IgM), 3 live flow cytometry cell-based assays (CBA-FACS, all MOG-IgG), and 2 ELISAs (both MOG-IgG). Results We found excellent agreement (96%) between the live CBAs for MOG-IgG for samples previously identified as clearly positive or negative from 4 different national testing centers. The agreement was lower with fixed CBA-IF (90%), and the ELISA showed no concordance with CBAs for detection of human MOG-IgG. All CBAs showed excellent interassay reproducibility. The agreement of MOG-IgG CBAs for borderline negative (77%) and particularly low positive (33%) samples was less good. Finally, most samples from healthy blood donors (97%) were negative for MOG-IgG in all CBAs. Conclusions Live MOG-IgG CBAs showed excellent agreement for high positive and negative samples at 3 international testing centers. Low positive samples were more frequently discordant than in a similar comparison of aquaporin-4 antibody assays. Further research is needed to improve international standardization for clinical care.Keywords
This publication has 36 references indexed in Scilit:
- Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disordersNeurology, 2014
- Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotypeNeurology, 2012
- Relationship Between NMO-Antibody and Anti–MOG Antibody in Optic NeuritisJournal of Neuro-Ophthalmology, 2012
- Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersJournal of Neuroinflammation, 2011
- Antibodies to MOG are transient in childhood acute disseminated encephalomyelitisNeurology, 2011
- Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseasesClinical Immunology, 2011
- Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system diseaseAnnals of Neurology, 2009
- Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple SclerosisThe Journal of Immunology, 2009
- Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured proteinNature Medicine, 2007
- A novel myelin-associated glycoprotein defined by a mouse monoclonal antibodyJournal of Neuroimmunology, 1984